Published in Lab Law Weekly, November 24th, 2006
Nanobac is a growing pharmaceutical company in the field of medical nanotechnology. The company is focused on developing methods to treat calcifying nanoparticles (CNPs), and by doing so, find more effective approaches to treating and preventing the cardiovascular, kidney and prostate diseases associated with them.
Nanotechnology is the realm of discovering and exploiting the special characteristics of materials at the atomic scale. A nanoparticle is generally considered to be anything less than 100 nanometers, or 100 billionths of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly